BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37839162)

  • 41. Establishment and characterization of two Epstein-Barr virus-positive gastric cancer cell lines with epitheliotropic M81 strain undergoing distinct viral and altered cellular expression profiles.
    Xu M; Zhang L; Feng J; Yang S; Wang Y; Wang Y; Chen M; Zhou L; Zhang J; Qin Q
    J Med Virol; 2023 Jan; 95(1):e28387. PubMed ID: 36478267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein-Barr Virus Regulates Endothelin-1 Expression through the ERK/FOXO1 Pathway in EBV-Associated Gastric Cancer.
    Liu W; Zhang Q; Zhang Y; Sun L; Xiao H; Luo B
    Microbiol Spectr; 2023 Feb; 11(1):e0089822. PubMed ID: 36475746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin.
    Lu J; Murakami M; Verma SC; Cai Q; Haldar S; Kaul R; Wasik MA; Middeldorp J; Robertson ES
    Virology; 2011 Feb; 410(1):64-75. PubMed ID: 21093004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration.
    Murakami M; Lan K; Subramanian C; Robertson ES
    J Virol; 2005 Feb; 79(3):1559-68. PubMed ID: 15650182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
    Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma.
    Nakayama A; Abe H; Kunita A; Saito R; Kanda T; Yamashita H; Seto Y; Ishikawa S; Fukayama M
    PLoS One; 2019; 14(1):e0211358. PubMed ID: 30695048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV.
    Minoura-Etoh J; Gotoh K; Sato R; Ogata M; Kaku N; Fujioka T; Nishizono A
    J Med Microbiol; 2006 Jul; 55(Pt 7):905-911. PubMed ID: 16772418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.
    Perez EM; Foley J; Tison T; Silva R; Ogembo JG
    Oncotarget; 2017 Mar; 8(12):19255-19273. PubMed ID: 27926486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.
    Lee EK; Kim SY; Noh KW; Joo EH; Zhao B; Kieff E; Kang MS
    Antiviral Res; 2014 Apr; 104():73-83. PubMed ID: 24486954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.
    Lin A; Wang S; Nguyen T; Shire K; Frappier L
    J Virol; 2008 Dec; 82(24):12009-19. PubMed ID: 18922874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival.
    Frappier L
    Viruses; 2012 Sep; 4(9):1537-1547. PubMed ID: 23170171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
    Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P
    World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maintenance of the viral episome is essential for the cell survival of an Epstein-Barr virus positive gastric carcinoma cell line.
    Oh ST; Kim M; Lee SK
    Arch Pharm Res; 2009 May; 32(5):729-36. PubMed ID: 19471888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells.
    Sonkar C; Verma T; Chatterji D; Jain AK; Jha HC
    BMC Cancer; 2020 Sep; 20(1):925. PubMed ID: 32993565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer.
    Jeong I; Kang SK; Kwon WS; Kim HJ; Kim KH; Kim HM; Lee A; Lee SK; Bogenrieder T; Chung HC; Rha SY
    J Cell Mol Med; 2018 Dec; 22(12):5899-5908. PubMed ID: 30247804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinicopathologic features and protein expression study of Epstein-Barr virus-associated gastric carcinoma in Guangzhou].
    Han J; He D; Feng ZY; Ding YG; Shao CK
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):798-803. PubMed ID: 21215093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1.
    Shen CL; Huang WH; Hsu HJ; Yang JH; Peng CW
    Antiviral Res; 2019 Apr; 164():123-130. PubMed ID: 30817940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism.
    Wang C; Wang H; Zhang Y; Guo W; Long C; Wang J; Liu L; Sun X
    Oncol Rep; 2017 Apr; 37(4):2109-2120. PubMed ID: 28259949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell specific internal translation efficiency of Epstein-Barr virus present in solid organ transplant patients.
    Isaksson A; Berggren M; Ekeland-Sjöberg K; Samuelsson T; Ricksten A
    J Med Virol; 2007 May; 79(5):573-81. PubMed ID: 17385682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen.
    Persson Berg L; Thomsson E; Hasi G; Bäckström M; Bergström T
    J Virol Methods; 2020 Oct; 284():113927. PubMed ID: 32650039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.